Chan R - Search Results

1

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial.

Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE, Smith SG, Martin N, Mayer B, Yancey SW, Sousa AR, Chan R, Hopkins C; SYNAPSE study investigators. Han JK, et al. Among authors: chan r. Lancet Respir Med. 2021 Oct;9(10):1141-1153. doi: 10.1016/S2213-2600(21)00097-7. Epub 2021 Apr 16. Lancet Respir Med. 2021. PMID: 33872587

2

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.

Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S. Maspero J, et al. Among authors: chan r. Clin Ther. 2008 Aug;30(8):1492-504. doi: 10.1016/j.clinthera.2008.07.018. Clin Ther. 2008. PMID: 18803991 Clinical Trial.

3

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial.

Watz H, Barnacle H, Hartley BF, Chan R. Watz H, et al. Among authors: chan r. Lancet Respir Med. 2014 Jan;2(1):63-72. doi: 10.1016/S2213-2600(13)70200-5. Epub 2013 Dec 5. Lancet Respir Med. 2014. PMID: 24461903 Clinical Trial.

4

Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma.

Chan R, Sousa AR, Mallett S, Hynds P, Homayoun-Valiani F, Tabberer M, Mehta R. Chan R, et al. Pulm Pharmacol Ther. 2016 Dec;41:19-24. doi: 10.1016/j.pupt.2016.09.002. Epub 2016 Sep 4. Pulm Pharmacol Ther. 2016. PMID: 27599598 Clinical Trial.

5

Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler versus a multi-dose inhaler in patients with chronic obstructive pulmonary disease.

Chan R, Sousa AR, Hynds P, Homayoun-Valiani F, Edwards D, Tabberer M. Chan R, et al. Pulm Pharmacol Ther. 2017 Apr;43:12-19. doi: 10.1016/j.pupt.2017.01.009. Epub 2017 Jan 21. Pulm Pharmacol Ther. 2017. PMID: 28115223 Clinical Trial.

6

Understanding the Patient Experience of Severe, Recurrent, Bilateral Nasal Polyps: A Qualitative Interview Study in the United States and Germany.

Hall R, Trennery C, Chan R, Gater A, Bradley H, Sikirica MV, von Maltzahn R, Sousa AR, Nelsen LM. Hall R, et al. Among authors: chan r. Value Health. 2020 May;23(5):632-641. doi: 10.1016/j.jval.2019.11.005. Epub 2020 Mar 11. Value Health. 2020. PMID: 32389229 Free article.

7

Reply.

Howarth P, Bachert C, Sousa A, Chan R. Howarth P, et al. Among authors: chan r. J Allergy Clin Immunol. 2020 Sep;146(3):683-684. doi: 10.1016/j.jaci.2020.05.053. Epub 2020 Jul 24. J Allergy Clin Immunol. 2020. PMID: 32713687 No abstract available.

8

From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases.

Pavord ID, Bel EH, Bourdin A, Chan R, Han JK, Keene ON, Liu MC, Martin N, Papi A, Roufosse F, Steinfeld J, Wechsler ME, Yancey SW. Pavord ID, et al. Among authors: chan r. Allergy. 2022 Mar;77(3):778-797. doi: 10.1111/all.15056. Epub 2021 Sep 16. Allergy. 2022. PMID: 34402066 Free PMC article. Review.

9

Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count.

Bachert C, Sousa AR, Han JK, Schlosser RJ, Sowerby LJ, Hopkins C, Maspero JF, Smith SG, Kante O, Karidi-Andrioti DE, Mayer B, Chan RH, Yancey SW, Chaker AM. Bachert C, et al. Among authors: chan rh. J Allergy Clin Immunol. 2022 May;149(5):1711-1721.e6. doi: 10.1016/j.jaci.2021.10.040. Epub 2022 Jan 7. J Allergy Clin Immunol. 2022. PMID: 35007624 Free article. Clinical Trial.

10

Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020].

Martin N, Papi A, Bratton DJ, Chan R, Howarth PH, Abbott CB, Keene ON, Bel EH. Martin N, et al. Among authors: chan r. Respir Med. 2022 Jan;191:106065. doi: 10.1016/j.rmed.2020.106065. Epub 2020 Jun 11. Respir Med. 2022. PMID: 35090690 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,725 results

Search Page